Back
Direxion Daily Real Estate Bull 3X ETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
64
DRN
Direxion Daily Real Estate Bull 3X ETF
Last Price:
12.52
Seasonality Move:
11.56%
Sell
32
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
57.10
Seasonality Move:
16.48%
Buy
64
Direxion Daily Real Estate Bull 3X ETF (DRN)
is a Buy
Is Direxion Daily Real Estate Bull 3X ETF a Buy, Sell or Hold?
- The current Direxion Daily Real Estate Bull 3X ETF [DRN] share price is $12.22. The Score for DRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- DRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $55.10. The Score for BIB is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DRN Stock Price Chart
What is Direxion Daily Real Estate Bull 3X ETF's stock price today?
-
The Direxion Daily Real Estate Bull 3X ETF share price today is $12.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRN is experiencing slight buying pressure.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $55.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
DRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 50.68 | Buy |
| Chaikin Money Flow: | 240850 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.71 - 12.73) | Sell |
| Bollinger Bands (100): | (10.53 - 13.09) | Buy |
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.32 | Sell |
| Relative Strength Index (14 RSI): | 34.01 | Sell |
| Chaikin Money Flow: | 7453 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.17 - 65.17) | Sell |
| Bollinger Bands (100): | (60.25 - 66.99) | Sell |
DRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.86 | Buy |
| 20-day SMA: | 12.06 | Buy |
| 50-day SMA: | 12.61 | Sell |
| 200-day SMA: | 10.26 | Buy |
| 8-day EMA: | 11.98 | Buy |
| 20-day EMA: | 12.09 | Buy |
| 50-day EMA: | 12.18 | Buy |
| 200-day EMA: | 10.85 | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.68 | Sell |
| 20-day SMA: | 60.68 | Sell |
| 50-day SMA: | 62.63 | Sell |
| 200-day SMA: | 59.92 | Sell |
| 8-day EMA: | 56.6 | Sell |
| 20-day EMA: | 59.52 | Sell |
| 50-day EMA: | 61.66 | Sell |
| 200-day EMA: | 60.17 | Sell |
Direxion Daily Real Estate Bull 3X ETF Earnings Growth & DRN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily Real Estate Bull 3X ETF Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||